BPC-157 + TB-500 - 5mg/5mg
BPC-157 + TB-500 - 5mg/5mg
Low stock: 9 left
Couldn't load pickup availability
To share

Collapsible content
Product description
BPC‑157 + TB-500 – Research Peptide Combination for Tissue Repair & Regenerative Research
The combination of BPC-157 and TB-500 is used in laboratories to investigate synergistic effects on tissue repair and regeneration. BPC-157 stimulates fibroblasts, angiogenesis, and connective tissue repair, while TB-500 (Thymosin Beta-4) supports actin migration and cell regeneration. Together, they provide a powerful preclinical model for tendon, muscle, ligament, nerve, and connective tissue repair studies and are used worldwide in studies of regenerative mechanisms.
How BPC‑157 + TB-500 works
Laboratory research shows that the combination of these peptides can modulate multiple recovery pathways:
- BPC‑157 promotes fibroblast activity, collagen formation and angiogenesis, and inhibits inflammatory pathways in tissue models.
- TB-500 stimulates actin migration and cell mobility, allowing damaged structures to reorganize and regenerate more quickly.
- The synergy between BPC-157 and TB-500 in models of tendon, muscle, and ligament repair results in improved structural integrity and tissue resistance.
- Research shows that combinations of peptides can be more effective in laboratory settings than individual peptides, which is useful for model validation and preclinical studies.
Benefits of BPC‑157 + TB-500
- Supports laboratory research into tissue repair , regeneration and inflammation modulation
- Synergistically enhances preclinical effects on tendons, ligaments, muscles and nerve tissue
- Promotes research into angiogenesis , collagen production and fibroblast migration
- Ideal for labs wanting to measure synergy between peptides in recovery models
- Suitable for studies focused on regenerative research , connective tissue structure and tissue integrity
- Supports reproduction of measurable research results with reliable analytical methods
Legal disclaimer
**All information is based on preclinical and laboratory studies. BPC-157 + TB-500 is not intended for human or veterinary use . All effects are based on animal and cell models.